Abstract:The aim of this study was to reduce the door-to-needle (DTN) time of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) through a comprehensive, hospital-based implementation strategy. The intervention involved a systemic literature review, identifying barriers to rapid IVT treatment at our hospital, setting target DTN time intervals, and building an evolving model for IVT candidate selection. The rate of non-in-hospital delay (DTN time ≤ 60 min) was set as the primary endpoint. A total of 348 IVT cases were enrolled in the study (202 and 146 in the pre- and post-intervention group, respectively). The median age was 61 years in both groups; 25.2% and 26.7% of patients in the pre- and post-intervention groups, respectively, were female. The post-intervention group had higher rates of dyslipidemia and minor stroke [defined as National Institutes of Health Stroke Scale (NIHSS) ≤ 3]; less frequent atrial fibrillation; higher numbers of current smokers, heavy drinkers, referrals, and multi-model head imaging cases; and lower NIHSS scores and blood sugar level (all P < 0.05). All parameters including DTN, door-to-examination, door-to-imaging, door-to-laboratory, and final-test-to-needle times were improved post-intervention (all P < 0.05), with net reductions of 63, 2, 4, 28, and 23 min, respectively. The rates of DTN time ≤ 60 min and onset-to-needle time ≤ 180 min were significantly improved by the intervention (pre: 9.9% vs. post: 60.3%; P < 0.001 and pre: 23.3% vs. post: 53.4%; P < 0.001, respectively), which was accompanied by an increase in the rate of neurological improvement (pre: 45.5% vs. post: 59.6%; P = 0.010), while there was no change in incidence of mortality or systemic intracranial hemorrhage at discharge (both P > 0.05). These findings indicate that it is possible to achieve a DTN time ≤ 60 min for up to 60% of hospitals in the current Chinese system, and that this logistical change can yield a notable improvement in the outcome of IVT patients.

The Current State, Barriers and Improving Strategies of Intravenous Thrombolysis for Acute Ischemic Stroke in China

Thrombolysis in Acute Ischemic Stroke: Issues and Options

Corrigendum to "imbalanced Regional Development of Acute Ischemic Stroke Care in Emergency Departments in China"

Improving In-Hospital Stroke Service Utilization (MISSION) to Shorten Thrombolytic Door-to-needle Time in Acute Ischemic Stroke Patients: A Cluster Randomized Controlled Trial

Prehospital Notification Procedure Improves Stroke Outcome by Shortening Onset to Needle Time in Chinese Urban Area.

Research Progress of Individualized Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator

The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke

Updates on intravenous thrombolytic therapy of acute ischemic stroke

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke in Hubei, China: a Survey of Thrombolysis Rate and Barriers.

Research progress on influencing factors and intervention measures of pre-hospital delays in acute ischemic stroke

[Recent Progress in Developing of Thrombolytic Agents for Ischemic Stroke].

Implementation of Regional Acute Stroke Care Map Increases Thrombolysis Rates for Acute Ischaemic Stroke in Chinese Urban Area in Only 3 Months

Stroke Thrombolysis Normalization Management:in Clinic Particular Conditions

The Clinical Study of Thrombolysis with rt-PA in Acute Ischemic Stroke

Thrombolytic drugs for acute ischemic stroke

Progress on Study of Thrombolysis with Recombinant Tissue Plasminogen Activators for Acute Ischaemic Stroke

Rates of Intravenous Thrombolysis and Endovascular Therapy for Acute Ischaemic Stroke in China Between 2019 and 2020.

Thrombolytic Strategies for Acute Ischemic Stroke

Generalization of the Right Acute Stroke Prevention Strategies in Reducing In-Hospital Delays.

Advances in the treatment of ischemic stroke with thrombolytic agents

Current Status of Intravenous Thrombolysis and Influence Factors of Pre-hospital Delay among Patients with Acute Ischemic Stroke